BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Galapagos Increases Share Capital Through Warrant Exercises

  December 7, 2015

   · 

  1 min read
• Drug Development

  AbbVie Release: IMBRUVICA (Ibrutinib) Phase 3 RAY Data Show Significant Reductions In Disease Progression Versus Temsirolimus In Relapsed/Refractory Mantle Cell Lymphoma Patients

  December 7, 2015

   · 

  13 min read
• BioCapital

  National Sheriffs’ Association And Purdue Pharma L.P. Lead Law Enforcement Training On Naloxone

  December 7, 2015

   · 

  3 min read
• Biotech Beach

  DiligenMed, Inc Release: A Novel, Highly Specific And Sensitive Hepatitis C Virus (HCV) Antigen Test System For One-Step Screening And Diagnosing Viremic HCV Infection Using Either Serum Or Urine Specimens

  December 7, 2015

   · 

  2 min read
• Drug Development

  Alnylam Reports Positive Phase I Study Results For Once-Monthly, Subcutaneous Fitusiran (ALN-AT3) In Patients With Hemophilia A And B

  December 7, 2015

   · 

  18 min read
• Drug Development

  Seattle Genetics Demonstrates Commitment To Improve Hodgkin Lymphoma (HL) Treatment Paradigm Through Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations At American Society of Hematology 2015

  December 7, 2015

   · 

  18 min read
• Drug Development

  Acetylon Pharmaceuticals Presents Data On The Use Of HDAC 6 Inhibitors Ricolinostat (ACY-1215) And ACY-241 In Combination With Pomalidomide For The Treatment Of Multiple Myeloma

  December 7, 2015

   · 

  7 min read
• Drug Development

  Global Blood Therapeutics Announces Positive Phase 1/2 Data Supporting Development Of GBT440 As A Potentially Disease-Modifying Therapy For Sickle Cell Disease

  December 7, 2015

   · 

  7 min read
• Drug Development

  GlycoMimetics, Inc. Presents Preclinical Data At American Society of Hematology Annual Meeting Showing GMI-1359 Enhances Efficacy Of Chemotherapy In FLT-3 AML Model

  December 7, 2015

   · 

  3 min read
• Lone Star Bio

  Lexicon Pharma To Present At The Oppenheimer 26th Annual Healthcare Conference

  December 7, 2015

   · 

  2 min read